Dynatronics Co. (DYNT) Receives Average Recommendation of “Strong Buy” from Brokerages

Shares of Dynatronics Co. (NASDAQ:DYNT) have received an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.

Brokers have set a one year consensus price target of $7.50 for the company, according to Zacks. Zacks has also assigned Dynatronics an industry rank of 160 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research upgraded shares of Dynatronics from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a report on Monday, January 1st.

Dynatronics (DYNT) opened at $2.90 on Friday. The firm has a market cap of $15.99, a PE ratio of -2.61 and a beta of -0.14. Dynatronics has a 1-year low of $2.10 and a 1-year high of $3.75. The company has a current ratio of 1.46, a quick ratio of 0.92 and a debt-to-equity ratio of 0.81.

Dynatronics (NASDAQ:DYNT) last announced its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.08. The business had revenue of $12.80 million for the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. research analysts anticipate that Dynatronics will post -0.09 earnings per share for the current year.

In related news, major shareholder Stuart Essig acquired 27,455 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The shares were acquired at an average cost of $2.77 per share, for a total transaction of $76,050.35. Following the acquisition, the insider now directly owns 856,169 shares in the company, valued at approximately $2,371,588.13. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Brian Larkin acquired 40,000 shares of the business’s stock in a transaction dated Thursday, November 30th. The shares were bought at an average price of $2.50 per share, for a total transaction of $100,000.00. Following the completion of the acquisition, the director now owns 80,276 shares in the company, valued at $200,690. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 369,015 shares of company stock worth $930,372. Insiders own 51.80% of the company’s stock.

An institutional investor recently bought a new position in Dynatronics stock. First Light Asset Management LLC bought a new position in shares of Dynatronics Co. (NASDAQ:DYNT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned approximately 2.72% of Dynatronics as of its most recent filing with the Securities and Exchange Commission. 18.17% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/20/dynatronics-co-dynt-receives-average-recommendation-of-strong-buy-from-brokerages.html.

Dynatronics Company Profile

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.

Get a free copy of the Zacks research report on Dynatronics (DYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply